Evaluating the Biological Effects of Bisphenol A Leaching During Clear Aligner Therapy: An Umbrella Review of
Noyonika Mallik1, Biswaroop Mohanty1, Sanghamitra Jena1
1Department of Orthodontics and Dentofacial Orthopaedics, Kalinga Institute of Dental Sciences, KIIT (Deemed to be University), Bhubaneswar, IND.
Abstract:
The rising demand for aesthetic and comfortable orthodontic treatments has led to the widespread use of clear aligner therapy (CAT), a modern alternative to traditional braces. This umbrella review examines the biological effects of bisphenol A (BPA), a synthetic compound commonly found in clear aligner materials, focusing on its potential health risks. BPA is known for its estrogen-mimicking properties and has been associated with endocrine disruption and increased cancer risk. This review synthesizes findings from systematic reviews and meta-analyses to evaluate BPA leaching in aligner therapy and its implications for patient safety. A total of 25 studies were screened, with three high-quality systematic reviews included in the final analysis. In vitro studies generally reported minimal cytotoxicity and weak estrogenic effects, while clinical trials suggested higher BPA levels due to the dynamic oral environment. Risk of bias was assessed, and forest and funnel plots indicated consistent findings with low immediate toxicity but raised concerns regarding long-term hormonal effects. Given these findings, further research is recommended to assess BPA exposure under real oral conditions and to develop BPA-free aligner materials. This review underscores the importance of biocompatibility in orthodontic materials and the need for rigorous safety assessments to protect patient health.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test


